Mealtime insulins, or fast-acting insulins, are injected before or after each meal to regulate the blood sugar. Type 1 diabetics require mealtime insulin injections as their pancreas does not produce insulin, whereas type 2 diabetics may only require mealtime insulin if they struggle with blood sugar control after meals or are not achieving their target A1C.
What is Fiasp indicated for?
Fiasp is a rapid-acting insulin indicated to improve blood sugar control in adults with type 1 or type 2 diabetes.
It will be available as a 10 ml multi-d0se vial, and a 3 ml single-use disposable FlexTouch Pen.
What dose of Fiasp will I need?
Your doctor will determine your exact dose based on your metabolic needs, blood sugar monitoring results, and your blood sugar control goal.
Dose adjustments may be needed if you experience changes in kidney or liver function, physical activity or meal patterns.
Is there anything unique about Fiasp?
Yes. Fiasp is a new formulation of NovoLog, in which the addition of niacinamide (vitamin B3) helps to increase the speed of the initial insulin absorption, resulting in an onset of appearance in the blood in approximately 2.5 minutes.
Is Fiasp approved for kids?
No. At this time Fiasp is not approved in pediatric patients.
For more information, see the press release from the manufacturer Novo Nordisk.